JP2024515544A5 - - Google Patents
Info
- Publication number
- JP2024515544A5 JP2024515544A5 JP2023561270A JP2023561270A JP2024515544A5 JP 2024515544 A5 JP2024515544 A5 JP 2024515544A5 JP 2023561270 A JP2023561270 A JP 2023561270A JP 2023561270 A JP2023561270 A JP 2023561270A JP 2024515544 A5 JP2024515544 A5 JP 2024515544A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocycloalkyl
- cycloalkyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171008P | 2021-04-05 | 2021-04-05 | |
| US63/171,008 | 2021-04-05 | ||
| US202263318486P | 2022-03-10 | 2022-03-10 | |
| US63/318,486 | 2022-03-10 | ||
| PCT/US2022/023546 WO2022216750A1 (en) | 2021-04-05 | 2022-04-05 | Opioid receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515544A JP2024515544A (ja) | 2024-04-10 |
| JP2024515544A5 true JP2024515544A5 (https=) | 2025-04-01 |
| JP7818620B2 JP7818620B2 (ja) | 2026-02-20 |
Family
ID=83546487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561270A Active JP7818620B2 (ja) | 2021-04-05 | 2022-04-05 | オピオイド受容体モジュレーター |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11634396B2 (https=) |
| EP (1) | EP4320105A4 (https=) |
| JP (1) | JP7818620B2 (https=) |
| KR (1) | KR20240005725A (https=) |
| AU (1) | AU2022254672A1 (https=) |
| BR (1) | BR112023020536A2 (https=) |
| CA (1) | CA3214397A1 (https=) |
| IL (1) | IL307453A (https=) |
| MX (1) | MX2023011761A (https=) |
| TW (1) | TW202304869A (https=) |
| WO (1) | WO2022216750A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202304869A (zh) | 2021-04-05 | 2023-02-01 | 美商艾碧奧戴股份有限公司 | 類鴉片受體調節劑 |
| CN117865851A (zh) * | 2024-01-10 | 2024-04-12 | 上海吉奉生物科技有限公司 | 一种Fmoc-2,6-二甲基酪氨酸的合成方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210669A (en) | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| JPH05194406A (ja) | 1991-11-12 | 1993-08-03 | Yoshitomi Pharmaceut Ind Ltd | 新規アミド化合物 |
| SE9600769D0 (sv) | 1996-02-28 | 1996-02-28 | Astra Ab | Compounds useful as analgesic |
| WO1998017636A1 (en) | 1996-10-22 | 1998-04-30 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
| US6900228B1 (en) | 1998-03-10 | 2005-05-31 | Research Triangle Institute | Opiate compounds, methods of making and methods of use |
| DE10252666A1 (de) | 2002-11-11 | 2004-08-05 | Grünenthal GmbH | N-Piperidyl-cyclohexan-Derivate |
| AU2003264676A1 (en) | 2003-06-27 | 2005-02-14 | Applications Technologiques Avancees, A.T.A. | Novel confinement or isolation box |
| EP1698375B1 (en) | 2003-12-25 | 2014-04-02 | Ono Pharmaceutical Co., Ltd. | Azetidine ring compounds and drugs comprising the same |
| EP1598341A1 (en) * | 2004-05-21 | 2005-11-23 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
| EP1604662A1 (en) | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus |
| WO2007115231A2 (en) | 2006-03-30 | 2007-10-11 | Chemocentryx, Inc. | Cxcr4 modulators |
| KR20080071476A (ko) | 2007-01-30 | 2008-08-04 | 주식회사 엘지생명과학 | 신규한 디펩티딜 펩티데이즈 ｉｖ(ｄｐｐ-ｉｖ) 저해제 |
| GB0813740D0 (en) | 2008-07-28 | 2008-09-03 | Angeletti P Ist Richerche Biologica | Therapeutic compounds |
| CN101823987B (zh) | 2009-03-06 | 2014-06-04 | 中国科学院上海药物研究所 | 一类新的dpp-ⅳ抑制剂及其制备方法和用途 |
| GB0919426D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| EP2539706B1 (en) | 2010-02-24 | 2015-03-04 | Research Triangle Institute | Arylpiperazine opioid receptor antagonists |
| WO2013006734A1 (en) | 2011-07-05 | 2013-01-10 | St. Jude Children's Research Hospital | Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity |
| WO2013033310A1 (en) | 2011-08-31 | 2013-03-07 | Theodore Mark Kamenecka | Modulators of rev-erb |
| EP2776400A1 (en) | 2011-11-09 | 2014-09-17 | Grünenthal GmbH | Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a co-containing group as vanilloid receptor ligands |
| WO2017007695A1 (en) | 2015-07-09 | 2017-01-12 | The Regents Of The University Of California | Mu opioid receptor modulators |
| WO2017035366A1 (en) | 2015-08-26 | 2017-03-02 | Incyte Corporation | Pyrrolopyrimidine derivatives as tam inhibitors |
| EP3565543A4 (en) | 2017-01-06 | 2020-10-14 | The Regents of The University of California | MU TYPE OPIOID RECEIVER MODULATORS |
| US10780078B2 (en) | 2017-08-17 | 2020-09-22 | The Regents Of The University Of California | Mu opioid receptor modulators |
| JP7402857B2 (ja) | 2018-04-04 | 2023-12-21 | エピオダイン，インク． | オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法 |
| TW202304869A (zh) | 2021-04-05 | 2023-02-01 | 美商艾碧奧戴股份有限公司 | 類鴉片受體調節劑 |
-
2022
- 2022-04-01 TW TW111112933A patent/TW202304869A/zh unknown
- 2022-04-05 US US17/714,030 patent/US11634396B2/en active Active
- 2022-04-05 KR KR1020237037915A patent/KR20240005725A/ko active Pending
- 2022-04-05 IL IL307453A patent/IL307453A/en unknown
- 2022-04-05 EP EP22785326.4A patent/EP4320105A4/en active Pending
- 2022-04-05 BR BR112023020536A patent/BR112023020536A2/pt unknown
- 2022-04-05 AU AU2022254672A patent/AU2022254672A1/en active Pending
- 2022-04-05 JP JP2023561270A patent/JP7818620B2/ja active Active
- 2022-04-05 WO PCT/US2022/023546 patent/WO2022216750A1/en not_active Ceased
- 2022-04-05 MX MX2023011761A patent/MX2023011761A/es unknown
- 2022-04-05 CA CA3214397A patent/CA3214397A1/en active Pending
-
2023
- 2023-02-13 US US18/168,155 patent/US12168648B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7779901B2 (ja) | 補体因子ｂ阻害剤及びその医薬組成物、製造方法並びに用途 | |
| JP2021523200A5 (https=) | ||
| JP2024515544A5 (https=) | ||
| CN101679287B (zh) | 烟碱型乙酰胆碱受体调节剂 | |
| CN104662021B (zh) | 新的双环吡啶酮类 | |
| CA3250950A1 (en) | HALOGEN SUBSTITUTION ISOINDOLINE COMPOUND AND ITS USE | |
| JP2014528433A5 (https=) | ||
| JP2022534704A5 (https=) | ||
| JP2006501295A5 (https=) | ||
| JP2000502679A (ja) | 鎮痛作用を有する新規化合物 | |
| JP2023518044A5 (https=) | ||
| JP2022553841A5 (https=) | ||
| JP2018065830A (ja) | ヘテロアリール化合物およびそれらの使用方法 | |
| CN107406423B (zh) | 强效γ-分泌酶调节剂 | |
| CN110248947A (zh) | Magl抑制剂 | |
| JP2022519696A5 (https=) | ||
| JP2011517443A5 (https=) | ||
| JP2021046404A5 (https=) | ||
| AU2014364565B2 (en) | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis | |
| CA3094336A1 (en) | Compounds and methods for ido and tdo modulation, and indications therefor | |
| CN105612158A (zh) | 促生长素抑制素受体亚型5(sstr5)拮抗剂 | |
| JP2017526659A5 (https=) | ||
| CN112292373A (zh) | 作为RORγt的调节剂的吡啶基吡唑类 | |
| JP2022524111A5 (https=) | ||
| JP2025527291A5 (https=) |